Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
163.80%
EBIT Growth (5y)
-53.92%
EBIT to Interest (avg)
-59.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
3.35
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.57
EV to EBIT
-4.81
EV to EBITDA
-5.45
EV to Capital Employed
2.56
EV to Sales
30.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-53.30%
ROE (Latest)
-19.17%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
RSI
Bullish
Bollinger Bands
Mildly Bearish
KST
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Shanghai Bao Pharmaceutical Co. Ltd.
Depreciation
At HKD 22.06 MM has Grown at 20.87%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
